On August 26, the Hong Kong Centre for Food Safety issued a brief official notice of under 300 words that thrust Junlebao into the media spotlight at a critical moment, as the dairy giant races toward the final stretch of its Hong Kong IPO.
Just six days earlier, on August 20, Junlebao had submitted its updated prospectus to the Hong Kong Stock Exchange, positioning the Hong Kong and Macau markets as the cornerstone of its internationalization strategy. Now, the company finds itself caught between a "high-quality, globalized" growth narrative aimed at capital markets and a hygiene violation notice from the very regulator in its listing destination. This food safety incident, unfolding during the IPO's key window, has exposed far more than just a quality control flaw in a single product batch.
Under the city's routine imported food monitoring program, all four samples taken from the same batch at the port were found to have bacterial colony counts at or above 10, exceeding the safety threshold set out in Hong Kong's Dairy Regulations (Cap. 132 sub. leg. AQ). Fortunately, unlike food safety incidents discovered only after products have entered circulation, all affected batches remained sealed in the importer's local Hong Kong warehouse at the time of the incident, never reaching the retail market and posing no direct health risk to ordinary consumers in Hong Kong.
The Hong Kong food safety authority also noted in its announcement that an elevated bacterial colony count reflects unsatisfactory overall hygiene conditions of the product, but does not necessarily mean it would directly cause food poisoning. Even so, regulators moved swiftly with firm measures, temporarily revoking the import permit for the affected product, requiring the importer to initiate a full supply chain traceability review, and mandating public disclosure of the cause of the incident.
As of August 29, 72 hours after the notice was published, Junlebao's headquarters had still not issued any formal public statement regarding the Hong Kong sampling incident. The only external response came through customer service channels, which said they were "not yet aware of the specific situation and have recorded the matter for the relevant department." This silent stance stands in stark contrast to the "full-process quality control and international standards" repeatedly emphasized in its prospectus.
In its freshly updated prospectus, Junlebao placed the Hong Kong and Macau markets at the core of its internationalization strategy. The company stated clearly that it would use Hong Kong and Macau as the first stop for its brand's global expansion, leveraging the high-standard endorsement of products supplied to Hong Kong to reinforce mainland consumers' perception of Junlebao as a brand synonymous with "high quality and rigorous standards." The prospectus specifically highlighted that core products such as Yuexianhuo and Jianchun had already entered the Hong Kong market, with plans to expand product coverage across the region and use it as a springboard into Southeast Asian markets.
But this notice from the Hong Kong Centre for Food Safety has effectively torn a hole in the core supporting pillar of Junlebao's IPO story. When it comes to food safety incidents at prospective listed companies, capital markets never look merely at whether anyone fell ill; they immediately assess the company's full-chain management capabilities, compliance awareness, and risk control standards. Given that the incident occurred in Hong Kong itself — the very venue of the planned listing — institutional investors and the Stock Exchange's listing review team will inevitably raise serious questions about this dairy giant with annual revenue exceeding RMB 20 billion and its ability to maintain quality control across different regions.
Just as concerning is the logic of consumer trust transmission. In the dairy industry, brand trust operates on a "one-strike-and-you're-out" basis. Consumers do not distinguish between problems arising in production versus transportation, nor do they dwell on whether elevated bacteria counts could actually cause poisoning. Once a product is flagged as non-compliant in Hong Kong's high-standard market, the brand equity built over years on a "zero-incident supply-to-Hong Kong quality" reputation instantly takes a hit. For Junlebao, which operates across both liquid milk and infant formula, this erosion of trust has the potential to ripple along its product lines into the infant formula segment, where tolerance for error is lowest, ultimately triggering an irreversible chain reaction of brand damage.
For a leading dairy company with annual revenue exceeding RMB 20 billion and 33 modern self-owned farms, an enforcement amount of RMB 502 is almost negligible. But the compliance management gap it exposes is anything but trivial. Zhangjiakou Junlebao Qizhi Farming is the backbone of Junlebao's dairy farming segment and the core platform for its "full industry chain integration" strategy. It manages operations of numerous core farms and directly determines the stability of milk quality at the source.
A core subsidiary overseeing hundreds of thousands of dairy cows with annual operating costs in the billions failing to resolve even a RMB 502 dispute in a timely manner, ending up subject to court enforcement, points to lax compliance awareness and gaps in internal management processes at the grassroots operational level. These are precisely the types of details in the dairy production chain most likely to evolve into food safety hazards — from equipment maintenance and sanitation at the source to temperature control during transportation, any small oversight can ultimately translate into substandard end products.
Junlebao's prospectus repeatedly emphasizes that its milk self-sufficiency rate reaches 63%, the highest among major domestic integrated dairy companies, positioning full supply chain self-control as its core competitive moat. Yet this RMB 502 execution record, combined with the bacteria count violation in Hong Kong, presents two unavoidable real-world counterexamples to the "from farm to table" safety narrative.
But this bacteria count incident directly exposes Junlebao's notable shortfall in adapting to cross-market standards. The requirements for total bacterial colony counts in dairy products under Hong Kong's Dairy Regulations differ clearly from mainland national standards. In the full process of production, warehousing, cross-border transportation, and port inspection for its Hong Kong-bound products, Junlebao clearly failed to establish a dedicated control system calibrated to the stricter standards. Even a brief temperature fluctuation during one transport leg, or a lapse in warehouse sanitation, could result in products failing port inspections in Hong Kong.
For a dairy company preparing to list in Hong Kong, this deficiency in cross-market compliance capability has long-term implications. As Junlebao looks to deepen its presence in Hong Kong and expand further into Singapore and other Southeast Asian markets, where food regulatory rules and testing standards all differ, capital markets will struggle to believe it can build a mature cross-regional quality control system if it cannot consistently meet Hong Kong's baseline standards.
At a deeper level, this incident also punctures the myth of "supply-to-Hong Kong quality" maintained by some domestic dairy enterprises. Many companies treat their Hong Kong-bound product lines as a separate "showcase project," allocating extra resources to ensure compliance while failing to replicate these high standards across their full regular production chains. When this "dual-standard quality control" approach is exposed by regulators at such a critical listing juncture, it deals a direct blow to both the company's brand credibility and its valuation in the capital markets.
Standing at the pivotal moment of its IPO sprint, Junlebao's challenge is not simply about "one batch of substandard product." The real question is how it will explain to consumers, to the Hong Kong Stock Exchange, and to institutional investors its full-chain quality control capabilities, cross-market compliance management, and crisis response capacity in the face of sudden public scrutiny. A timely official statement and a complete traceability and rectification plan are the pre-listing essentials this leading dairy company most urgently needs to deliver.